PT  - JOURNAL ARTICLE
AU  - Burns, Angus C.
AU  - Windred, Daniel P.
AU  - Rutter, Martin K.
AU  - Olivier, Patrick
AU  - Vetter, Céline
AU  - Saxena, Richa
AU  - Lane, Jacqueline M.
AU  - Phillips, Andrew J. K.
AU  - Cain, Sean W.
TI  - Low daytime light and bright night-time light are associated with psychiatric disorders: an objective light study in >85,000 UK Biobank participants
AID  - 10.1101/2022.10.16.22280934
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.10.16.22280934
4099  - http://medrxiv.org/content/early/2022/12/12/2022.10.16.22280934.short
4100  - http://medrxiv.org/content/early/2022/12/12/2022.10.16.22280934.full
AB  - Circadian rhythm disturbance is a common feature of many psychiatric disorders. Light is the primary input to the circadian clock, with daytime light strengthening rhythms and night light disrupting them. Therefore, habitual light exposure may represent an environmental risk factor for susceptibility to psychiatric disorders. We performed the largest to-date cross-sectional analysis of light, sleep, physical activity, and mental health (n = 86,772 adults; aged 62.4 ± 7.4 years; 57% women). We examined the independent association of day and night light exposure with covariate-adjusted risk for psychiatric disorders and self-harm. Greater night light exposure was associated with increased risk for major depressive disorder, generalized anxiety disorder, PTSD, psychosis, bipolar disorder, and self-harm behavior. Independent of night light, greater day light exposure was associated with reduced risk for major depressive disorder, PTSD, psychosis, and self-harm behavior. These findings were robust to adjustment for sociodemographics, photoperiod, physical activity, and sleep quality. Avoiding light at night and seeking light during the day may be a simple and effective, non-pharmacological means of broadly improving mental health.Competing Interest StatementAJKP and SWC have received research funding from Delos and Versalux, and they are co-founders and co-directors of Circadian Health Innovations PTY LTD. SWC has also received research funding from Beacon Lighting and has consulted for Dyson. PO was a co-founder of Axivity Ltd and a Director until 2015. CV is a board member of the Working Time Society and a research committee member for DiME. ACB: none; DPW: none; MKR: none; RS: none; JML: none.Funding StatementFunded in part by the Australian Government Research Training Program and National Health and Medical Research Council (NHMRC; project number = GNT1183472).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used ONLY openly available human data originally located at the UK Biobank.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis work utilized the UK Biobank resource (application 6818; Martin Rutter).